Summit Therapeutics Inc. (SMMT) /
The revenue of Summit Therapeutics Inc. over the past 8 years
Chart Summit Therapeutics Inc.: revenue, fiscal 2018–2025 Open the chart →Summit Therapeutics Inc. reported revenue of $0 in fiscal 2024. In fiscal 2018 it was $16.1M. Year over year, revenue rose twice and fell 3 times. In these years the highest was $57.09M in fiscal 2019; the lowest $0 in fiscal 2023. The largest one-year move was in fiscal 2019: up 254%, from $16.1M to $57.09M. No revenue figure is on file for fiscal 2025.
Year by year
| Fiscal year | Revenue |
|---|---|
| 2025ended Dec 31, 2025 | — |
| 2024ended Dec 31, 2024 | $0 |
| 2023ended Dec 31, 2023 | $0 |
| 2022ended Dec 31, 2022 | $705K |
| 2021ended Dec 31, 2021 | $1.81M |
| 2020ended Dec 31, 2020 | $860K |
| 2019ended Jan 31, 2019 | $57.09M |
| 2018ended Jan 31, 2018 | $16.1M |
Fiscal years as Summit Therapeutics Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Summit Therapeutics Inc.
- The profitability of Summit Therapeutics Inc.
- The cash flow of Summit Therapeutics Inc.
- The debt of Summit Therapeutics Inc.
- All of Summit Therapeutics Inc.'s financials, charted
Companies of a similar size
- DVADAVITA INC.
- WTSWATTS WATER TECHNOLOGIES INC
- FDSFACTSET RESEARCH SYSTEMS INC.
- AITAPPLIED INDUSTRIAL TECHNOLOGIES, INC.
- ALLYAlly Financial Inc.
Not investment advice. This page shows what Summit Therapeutics Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.